Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Oct 1;98(7):1659–1666. doi: 10.1172/JCI118961

Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells.

F Fais 1, B Sellars 1, F Ghiotto 1, X J Yan 1, M Dono 1, S L Allen 1, D Budman 1, K Dittmar 1, J Kolitz 1, S M Lichtman 1, P Schulman 1, M Schuster 1, V P Vinciguerra 1, K Rai 1, F K Stevenson 1, P K Gregersen 1, M Ferrarini 1, N Chiorazzi 1
PMCID: PMC507600  PMID: 8833916

Abstract

Chronic lymphocytic leukemia (CLL) usually involves the expansion of a clone of CD5+ B cells synthesizing IgM antibodies. These B cells appear to be blocked at the antigen receptor-expressing stage of B cell differentiation and are thought not to undergo an isotype class switch to IgG or IgA production. In vivo and in vitro studies suggest, however, that in some instances terminal differentiation and isotype switching can occur. To test the hypothesis that in vivo isotype class switching occurs in IgM+ B-type CLL cells, we analyzed the PBMC of 19 CLL patients for the presence of transcripts encoding the rearranged CLL V(H)DJ(H) associated with either gamma or alpha H chains. The molecular data indicate that approximately 50% of B-CLL patients have amplifications of IgM+ B cells that undergo an isotype class switch. Switching to IgA appears to occur more often than to IgG; also, switching can involve different IgG subclasses in individual patients. In many instances, these CLL-related gamma and alpha transcripts are much more plentiful than those of normal B cells that produce the same isotype. These switched transcripts do not reveal evidence for the accumulation of significant numbers of new V(H) gene mutations. The cellular data indicate that B cells with lesser amounts of surface membrane IgD and higher IgM/IgD ratios are more likely to undergo this switching process. Furthermore, B cells expressing IgG and IgA of the same idiotype or V(H) family and the same CDR3 length as those of the CLL IgM+ clone can be identified in the blood of patients studied using multiparameter immunofluorescence analyses. Collectively, these data suggest that not all members of a B-CLL clone are frozen at the surface membrane Ig-expressing stage of B cell maturation, and that some members can switch to the production of non-IgM isotypes. The occurrence of switching without the accumulation of V gene mutations indicates that the processes of differentiation and diversification are not linked.

Full Text

The Full Text of this article is available as a PDF (256.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrzejewski C., Jr, Young P. J., Cines D. B., Silberstein L. E. Heterogeneity of human red cell autoantibodies assessed by isoelectric focusing. Transfusion. 1991 Mar-Apr;31(3):236–244. doi: 10.1046/j.1537-2995.1991.31391165173.x. [DOI] [PubMed] [Google Scholar]
  2. Bertoli L. F., Kubagawa H., Borzillo G. V., Burrows P. D., Schreeder M. T., Carroll A. J., Cooper M. D. Bone marrow origin of a B-cell lymphoma. Blood. 1988 Jul;72(1):94–101. [PubMed] [Google Scholar]
  3. Billadeau D., Ahmann G., Greipp P., Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med. 1993 Sep 1;178(3):1023–1031. doi: 10.1084/jem.178.3.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borche L., Lim A., Binet J. L., Dighiero G. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood. 1990 Aug 1;76(3):562–569. [PubMed] [Google Scholar]
  5. Bröker B. M., Klajman A., Youinou P., Jouquan J., Worman C. P., Murphy J., Mackenzie L., Quartey-Papafio R., Blaschek M., Collins P. Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies. J Autoimmun. 1988 Oct;1(5):469–481. doi: 10.1016/0896-8411(88)90068-6. [DOI] [PubMed] [Google Scholar]
  6. Corradini P., Boccadoro M., Voena C., Pileri A. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas. J Exp Med. 1993 Sep 1;178(3):1091–1096. doi: 10.1084/jem.178.3.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deane M., Norton J. D. Immunoglobulin gene 'fingerprinting': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. Br J Haematol. 1991 Mar;77(3):274–281. doi: 10.1111/j.1365-2141.1991.tb08570.x. [DOI] [PubMed] [Google Scholar]
  8. Deegan M. J., Abraham J. P., Sawdyk M., Van Slyck E. J. High incidence of monoclonal proteins in the serum and urine of chronic lymphocytic leukemia patients. Blood. 1984 Dec;64(6):1207–1211. [PubMed] [Google Scholar]
  9. Dighiero G., Travade P., Chevret S., Fenaux P., Chastang C., Binet J. L. B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL. Blood. 1991 Oct 15;78(8):1901–1914. [PubMed] [Google Scholar]
  10. Dono M., Hashimoto S., Fais F., Trejo V., Allen S. L., Lichtman S. M., Schulman P., Vinciguerra V. P., Sellars B., Gregersen P. K. Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. Blood. 1996 Feb 15;87(4):1586–1594. [PubMed] [Google Scholar]
  11. Ebeling S. B., Schutte M. E., Logtenberg T. Molecular analysis of VH and VL regions expressed in IgG-bearing chronic lymphocytic leukemia (CLL): further evidence that CLL is a heterogeneous group of tumors. Blood. 1993 Sep 1;82(5):1626–1631. [PubMed] [Google Scholar]
  12. Engelfriet C. P., Overbeeke M. A., von dem Borne A. E. Autoimmune hemolytic anemia. Semin Hematol. 1992 Jan;29(1):3–12. [PubMed] [Google Scholar]
  13. Friedman D. F., Moore J. S., Erikson J., Manz J., Goldman J., Nowell P. C., Silberstein L. E. Variable region gene analysis of an isotype-switched (IgA) variant of chronic lymphocytic leukemia. Blood. 1992 Nov 1;80(9):2287–2297. [PubMed] [Google Scholar]
  14. Fu S. M., Chiorazzi N., Kunkel H. G., Halper J. P., Harris S. R. Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med. 1978 Dec 1;148(6):1570–1578. doi: 10.1084/jem.148.6.1570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fu S. M., Winchester R. J., Feizi T., Walzer P. D., Kunkel H. G. Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc Natl Acad Sci U S A. 1974 Nov;71(11):4487–4490. doi: 10.1073/pnas.71.11.4487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Grogan T. M., Durie B. G., Lomen C., Spier C., Wirt D. P., Nagle R., Wilson G. S., Richter L., Vela E., Maxey V. Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features. Blood. 1987 Oct;70(4):932–942. [PubMed] [Google Scholar]
  17. Harousseau J. L., Flandrin G., Tricot G., Brouet J. C., Seligmann M., Bernard J. Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: a study of 25 cases. Cancer. 1981 Sep 15;48(6):1302–1308. doi: 10.1002/1097-0142(19810915)48:6<1302::aid-cncr2820480609>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  18. Hashimoto S., Dono M., Wakai M., Allen S. L., Lichtman S. M., Schulman P., Vinciguerra V. P., Ferrarini M., Silver J., Chiorazzi N. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med. 1995 Apr 1;181(4):1507–1517. doi: 10.1084/jem.181.4.1507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jain R., Roncella S., Hashimoto S., Carbone A., Francia di Celle P., Foa R., Ferrarini M., Chiorazzi N. A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J Immunol. 1994 Jul 1;153(1):45–52. [PubMed] [Google Scholar]
  20. Jensen G. S., Mant M. J., Pilarski L. M. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient. Am J Hematol. 1992 Nov;41(3):199–208. doi: 10.1002/ajh.2830410311. [DOI] [PubMed] [Google Scholar]
  21. Juliusson G., Robèrt K. H., Hammarström L., Smith C. I., Biberfeld G., Gahrton G. Mitogen-induced switching of immunoglobulin heavy-chain class secretion in chronic B-lymphocytic leukaemia and immunocytoma cell populations. Scand J Immunol. 1983 Jan;17(1):51–59. doi: 10.1111/j.1365-3083.1983.tb00765.x. [DOI] [PubMed] [Google Scholar]
  22. Kipps T. J., Carson D. A. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood. 1993 May 15;81(10):2475–2487. [PubMed] [Google Scholar]
  23. Kipps T. J. Immunoglobulin genes in chronic lymphocytic leukemia. Blood Cells. 1993;19(3):615–632. [PubMed] [Google Scholar]
  24. Kipps T. J., Tomhave E., Chen P. P., Carson D. A. Autoantibody-associated kappa light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. Implications for etiology and immunotherapy. J Exp Med. 1988 Mar 1;167(3):840–852. doi: 10.1084/jem.167.3.840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kubagawa H., Vogler L. B., Capra J. D., Conrad M. E., Lawton A. R., Cooper M. D. Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J Exp Med. 1979 Oct 1;150(4):792–807. doi: 10.1084/jem.150.4.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. LEDDY J. P., BAKEMEIER R. F. STRUCTURAL ASPECTS OF HUMAN ERYTHROCYTE AUTOANTIBODIES. I. L CHAIN TYPES AND ELECTROPHORETIC DISPERSION. J Exp Med. 1965 Jan 1;121:1–17. doi: 10.1084/jem.121.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Litwin S. D., Balaban S., Eyster M. E. Gm allotype preference in erythrocyte IgG antibodies of patients with autoimmune hemolytic anemia. Blood. 1973 Aug;42(2):241–246. [PubMed] [Google Scholar]
  28. MacLennan I. C., Liu Y. J., Oldfield S., Zhang J., Lane P. J. The evolution of B-cell clones. Curr Top Microbiol Immunol. 1990;159:37–63. doi: 10.1007/978-3-642-75244-5_3. [DOI] [PubMed] [Google Scholar]
  29. Mayumi M., Kubagawa H., Omura G. A., Gathings W. E., Kearney J. F., Cooper M. D. Studies on the clonal origin of human B cell leukemia using monoclonal anti-idiotype antibodies. J Immunol. 1982 Aug;129(2):904–910. [PubMed] [Google Scholar]
  30. Meeker T. C., Grimaldi J. C., O'Rourke R., Loeb J., Juliusson G., Einhorn S. Lack of detectable somatic hypermutation in the V region of the Ig H chain gene of a human chronic B lymphocytic leukemia. J Immunol. 1988 Dec 1;141(11):3994–3998. [PubMed] [Google Scholar]
  31. Mercolino T. J., Arnold L. W., Hawkins L. A., Haughton G. Normal mouse peritoneum contains a large population of Ly-1+ (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J Exp Med. 1988 Aug 1;168(2):687–698. doi: 10.1084/jem.168.2.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mestecky J., McGhee J. R. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol. 1987;40:153–245. doi: 10.1016/s0065-2776(08)60240-0. [DOI] [PubMed] [Google Scholar]
  33. Mestecky J., Winchester R. J., Hoffman T., Kunkel H. G. Parallel synthesis of immunoglobulins and J chain in pokeweed mitogen-stimulated normal cells and in lymphoblastoid cell lines. J Exp Med. 1977 Mar 1;145(3):760–765. doi: 10.1084/jem.145.3.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Miller R. H., Linet M. S., Van Natta M. L., McCaffrey L. D., Humphrey R. L. Serum protein electrophoresis patterns in chronic lymphocytic leukemia. Clinical and epidemiologic correlations. Arch Intern Med. 1987 Sep;147(9):1614–1617. [PubMed] [Google Scholar]
  35. Okamoto M., Murakami M., Shimizu A., Ozaki S., Tsubata T., Kumagai S., Honjo T. A transgenic model of autoimmune hemolytic anemia. J Exp Med. 1992 Jan 1;175(1):71–79. doi: 10.1084/jem.175.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood. 1975 Aug;46(2):219–234. [PubMed] [Google Scholar]
  37. Rassenti L. Z., Kipps T. J. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia. J Exp Med. 1993 Apr 1;177(4):1039–1046. doi: 10.1084/jem.177.4.1039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Richter M. N. Generalized Reticular Cell Sarcoma of Lymph Nodes Associated with Lymphatic Leukemia. Am J Pathol. 1928 Jul;4(4):285–292.7. [PMC free article] [PubMed] [Google Scholar]
  39. Sarfati M., Luo H., Delespesse G. IgE synthesis by chronic lymphocytic leukemia cells. J Exp Med. 1989 Nov 1;170(5):1775–1780. doi: 10.1084/jem.170.5.1775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Shin E. K., Matsuda F., Nagaoka H., Fukita Y., Imai T., Yokoyama K., Soeda E., Honjo T. Physical map of the 3' region of the human immunoglobulin heavy chain locus: clustering of autoantibody-related variable segments in one haplotype. EMBO J. 1991 Dec;10(12):3641–3645. doi: 10.1002/j.1460-2075.1991.tb04930.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Silverman G. J., Sasano M., Wormsley S. B. Age-associated changes in binding of human B lymphocytes to a VH3-restricted unconventional bacterial antigen. J Immunol. 1993 Nov 15;151(10):5840–5855. [PubMed] [Google Scholar]
  42. Stevenson F. K., Wrightham M., Glennie M. J., Jones D. B., Cattan A. R., Feizi T., Hamblin T. J., Stevenson G. T. Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. Blood. 1986 Aug;68(2):430–436. [PubMed] [Google Scholar]
  43. Sthoeger Z. M., Sthoeger D., Shtalrid M., Sigler E., Geltner D., Berrebi A. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia. Am J Hematol. 1993 Aug;43(4):259–264. doi: 10.1002/ajh.2830430406. [DOI] [PubMed] [Google Scholar]
  44. Sthoeger Z. M., Wakai M., Tse D. B., Vinciguerra V. P., Allen S. L., Budman D. R., Lichtman S. M., Schulman P., Weiselberg L. R., Chiorazzi N. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med. 1989 Jan 1;169(1):255–268. doi: 10.1084/jem.169.1.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sun T., Susin M., Desner M., Pergolizzi R., Cuomo J., Koduru P. The clonal origin of two cell populations in Richter's syndrome. Hum Pathol. 1990 Jul;21(7):722–728. doi: 10.1016/0046-8177(90)90032-z. [DOI] [PubMed] [Google Scholar]
  46. Tötterman T. H., Nilsson K., Sundström C. Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature. 1980 Nov 13;288(5787):176–178. doi: 10.1038/288176a0. [DOI] [PubMed] [Google Scholar]
  47. Vogler L. B., Preud'homme J. L., Seligmann M., Gathings W. E., Crist W. M., Cooper M. D., Bollum F. J. Diversity of immunoglobulin expression in leukaemic cells resembling B-lymphocyte precursors. Nature. 1981 Mar 26;290(5804):339–341. doi: 10.1038/290339a0. [DOI] [PubMed] [Google Scholar]
  48. Wakai M., Hashimoto S., Omata M., Sthoeger Z. M., Allen S. L., Lichtman S. M., Schulman P., Vinciguerra V. P., Diamond B., Dono M. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing. Autoimmunity. 1994;19(1):39–48. doi: 10.3109/08916939409008007. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES